Clinical Trial Update: A Study of HS235 for Treatment of Pulmonary Arterial Hypertension (PAH) in Adults [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating HS235 for treatment of pulmonary arterial hypertension in adults; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• HS235

Snippet

Sponsor: 35Pharma Inc | Conditions: Pulmonary Arterial Hypertension | Phase 1 | Status: NOT_YET_RECRUITING